Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
Exploring telehealth options like Doctronic.ai can provide affordable access to medical consultations and guidance on managing costs and treatment plans
Melanotan 1 , also designated Afamelanotide and is a synthetic tridecapeptide melanocortin receptor agonist and one of the most extensively characterised MC1R-selective research compounds available to laboratories in Ireland , a metabolically stabilised linear analogue of alpha-melanocyte-stimulating hormone (-MSH) incorporating Nle4 and D-Phe7 substitutions that confer proteolytic resistance and enhanced MC1R binding affinity while preserving the natural -MSH peptide backbone, producing potent and sustained melanogenesis, photoprotection, and anti-inflammatory effects through MC1R activation in melanocytes, keratinocytes, and immune cells, making it an indispensable research tool for studying MC1R receptor pharmacology and downstream melanogenesis signal transduction, ultraviolet radiation-independent melanin synthesis and skin pigmentation biology, MC1R-mediated photoprotection and DNA damage prevention mechanisms, the anti-inflammatory biology of melanocortin receptor activation in skin and systemic immune contexts, erythropoietic protoporphyria biology and photoprotection research, MC1R genetics and the relationship between receptor polymorphisms and pigmentation phenotype, and the comparative pharmacology of melanocortin receptor agonists across the MC1R through MC5R receptor family, Researchers and institutions across Ireland can source verified, research-grade Melanotan 1 directly from our Irish peptide supply, with domestic-speed dispatch and complete batch documentation
However, the overall prognosis may depend upon the severity of the signs and symptoms of any underlying disorder (if any present) Who gets Melanotic Macules of Oral Mucosa
Within the body, glutathione is produced from three amino acids: L-cysteine, glycine and L-glutamic acid
Between 2005 and 2015, she worked at the Polish Academy of Sciences, focusing on the development and synthesis of biologically active compounds, particularly those with analgesic and neuroprotective properties
The aforementioned drastic increase in GLP-1 use comes as a result of increased accessibility through recent years of FDA policy expansion regarding permissibility of compounding pharmacies
